Insight Pharmaceuticals LLC
Industry
- Pharmaceuticals
- OTC, Consumer
- In Vitro Diagnostics
- Urine-based Testing
- Chemistry, Immunoassay
Latest on Insight Pharmaceuticals LLC
Private equity firms continue their investment spree in the consumer health products sector, keeping it a hotbed for mergers and acquisitions, says private equity manager Slava Leykind. Investors' int
Private equity firms continue their investment spree in the consumer health products sector, keeping it a hotbed for mergers and acquisitions, says private equity manager Slava Leykind. Investors' int
Private equity firms continue their investment spree in the consumer health products sector, keeping it a hotbed for mergers and acquisitions, says private equity manager Slava Leykind. Investors' int
Financings Biopharma companies closed out 2016 with $9.6 billion in financing. ( See Exhibit 1. ) Not only was this a 30% increase over Q3's $7.4 billion, it was also the strongest quarter of the year